Use of PROC MIXED in the analysis of repeated measures data from a clinical trial in obsessive compulsive disorder

被引:0
|
作者
Bushnell, W [1 ]
Steiner, M [1 ]
机构
[1] SmithKline Beecham, Collegeville, PA 19426 USA
关键词
D O I
暂无
中图分类号
TP31 [计算机软件];
学科分类号
081202 ; 0835 ;
摘要
The subject of this paper is the analysis of data from a randomized, parallel group, multicenter clinical trial in patients with Obsessive Compulsive Disorder (OCD). The purpose of the study was to evaluate the efficacy and safety of three dose levels of Paxil(TM)* (paroxetine HCl) versus placebo. The level of the patients' illness was measured using the Yale Brown Obsessive Compulsive Scale (YBOCS) at baseline and at weeks 1, 2, 3, 4, 6, 8, 10, and 12. The data set included data points which were missing due to skipped visits and patient dropouts. PROC MIXED of the SAS System was used in two alternative approaches to the analysis of the data from this study. The first is a repeated measures analysis. Secondly, PROC MIXED was used in a random coefficient regression analysis. In this analysis the hypothesis of interest was the differences in slopes (rates of improvement) for the doses of Paxil and placebo.
引用
收藏
页码:1341 / 1346
页数:6
相关论文
共 50 条
  • [1] An introduction to the analysis of repeated measures for continuous response data using PROC GLM and PROC MIXED
    Hamer, RM
    Simpson, PM
    PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, 1998, : 355 - 358
  • [2] Substance use disorders in an obsessive compulsive disorder clinical sample
    Mancebo, Maria C.
    Grant, Jon E.
    Pinto, Anthony
    Eisen, Jane L.
    Rasmussen, Steven A.
    JOURNAL OF ANXIETY DISORDERS, 2009, 23 (04) : 429 - 435
  • [3] CORTICAL MEASURES TO DISSOCIATE HOARDING DISORDER FROM OBSESSIVE-COMPULSIVE DISORDER
    Figueira, Jessica
    Chapman, Elizabeth
    Zakrzewski, Jessica
    Mathews, Carol
    Keil, Andreas
    PSYCHOPHYSIOLOGY, 2021, 58 : S84 - S84
  • [4] On the practical application of mixed effects models for repeated measures to clinical trial data
    Andersen, Scott W.
    Millen, Brian A.
    PHARMACEUTICAL STATISTICS, 2013, 12 (01) : 7 - 16
  • [5] Seasonal Variations in Obsessive-Compulsive Disorder: Analysis of Prospective-Clinical Data
    Altintas, Ebru
    Kutuk, Meryem Ozlem
    Tufan, A. Evren
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2021, 58 (03): : 193 - 199
  • [6] AN OPEN CLINICAL-TRIAL OF ZIMELDINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER
    FONTAINE, R
    CHOUINARD, G
    INY, L
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (02): : 326 - 332
  • [7] The use of MIXED models in the analysis of animal experiments with repeated measures data
    Wang, Z
    Goonewardene, LA
    CANADIAN JOURNAL OF ANIMAL SCIENCE, 2004, 84 (01) : 1 - 11
  • [8] Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial
    Mowla, Arash
    Modarresi, Farzaneh
    Dastgheib, Seyed Ali
    ASIAN JOURNAL OF PSYCHIATRY, 2018, 38 : 92 - 95
  • [9] Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder
    Sharma, Lavanya P.
    Thamby, Abel
    Balachander, Srinivas
    Janardhanan, C. Narayanaswamy
    Jaisoorya, T. S.
    Arumugham, Shyam Sundar
    Reddy, Y. C. Janardhan
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 52
  • [10] A study of the Repeated Actions Diary in patients suffering from obsessive compulsive disorder
    Bouvard, Martine
    Fournet, Nathalie
    Denis, Anne
    Achachi, Ouafae
    Purdon, Christine
    CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2020, 27 (02) : 228 - 238